Develop, manufacture, and sell genomic analysis oncology diagnostics
Food and Drug Administration regulatory policy generally
S. 456 (RACE for Children Act), all provisions
H.R. 2430 (FDA Reauthorization Act of 2017), Title V, regarding RACE for Children Act and pediatric cancer treatment
H.R. 3358 and S. 1771 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018), regarding National Institutes of Health funding level
H.R. 3354 (Make America Secure and Prosperous Appropriations Act, 2018), Division F -- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018, regarding National Institutes of Health funding level Medicare program policy for regulatory approval and reimbursement for new oncology diagnostic technologies
"14 Day Rule" regarding billing for clinical laboratory services
Implementation of Protecting Access to Medicare Act regarding reimbursement for clinical laboratory services
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARENTFOX SCHIFF LLP
1717 K Street, NW, Washington, DC, 20006, US
DAN RENBERG DAN RENBERG SONJA NESBIT PHILIP ENGLISH (U.S. Representative)
U.S. Representative